QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (140) Citing Articles via Google Scholar Google Scholar Articles by Castaneda, E. Articles by Robinson, T. E. Search for Related Content PubMed PubMed Citation Articles by Castaneda, E. Articles by Robinson, T. E.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 10, 1847-1854, Copyright © 1990 by Society for Neuroscience

ARTICLE

Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size

E Castaneda, IQ Whishaw and TE Robinson
Department of Psychology, University of Lethbridge, Alberta, Canada.

Intracerebral microdialysis was used to measure the extracellular concentration of striatal dopamine (DA) and its metabolites in freely moving rats depleted of DA by the bilateral infusion of 6- hydroxydopamine into the substantia nigra approximately 1 month earlier. It was found that the basal extracellular concentration of DA remained within the same range as seen in control animals until the size of the lesion exceeded 80% (estimated by the postmortem tissue concentration of DA). In animals with an 80-95% lesion there was only a modest decrease in basal extracellular DA, but as lesion size exceeded 95% there was a marked drop in the basal extracellular concentration of DA. In contrast, the basal extracellular concentration of the DA metabolites showed a more steady decline as a function of lesion size. To determine the ability of the residual population of DA terminals to further increase DA release upon increased demand, animals were given a challenge injection of 1.5 mg/kg of d-amphetamine. Amphetamine-evoked DA release remained within the control range until lesion size exceeded 95%. These results provide direct confirmation for the hypothesis that following recovery from partial bilateral damage to the nigrostriatal DA system in adulthood, there are presynaptic compensatory changes in the remaining population of DA neurons sufficient to "normalize" the extracellular concentration of striatal DA. It is suggested that this normalization of extracellular DA is responsible for the sparing of function seen following the loss of up to 80% of the DA innervation to the striatum and contributes to the recovery of function seen after even more extensive damage (80-95%).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				P. Blier Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development J Psychopharmacol, August 1, 2008; 22(6): 587 - 589. [PDF]

				D. L. Robinson, B. J. Venton, M. L.A.V. Heien, and R. M. Wightman Detecting Subsecond Dopamine Release with Fast-Scan Cyclic Voltammetry in Vivo Clin. Chem., October 1, 2003; 49(10): 1763 - 1773. [Abstract] [Full Text] [PDF]

				C. Flores, D. Rodaros, and J. Stewart Long-Lasting Induction of Astrocytic Basic Fibroblast Growth Factor by Repeated Injections of Amphetamine: Blockade by Concurrent Treatment with a Glutamate Antagonist J. Neurosci., November 15, 1998; 18(22): 9547 - 9555. [Abstract] [Full Text] [PDF]

				N. Altier and J. Stewart Dopamine Receptor Antagonists in the Nucleus Accumbens Attenuate Analgesia Induced by Ventral Tegmental Area Substance P or Morphine and by Nucleus Accumbens Amphetamine J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 208 - 215. [Abstract] [Full Text]

				B. A. Sabel Unrecognized Potential of Surviving Neurons: : Within-systems Plasticity, Recovery of Function, and the Hypothesis of Minimal Residual Structure Neuroscientist, November 1, 1997; 3(6): 366 - 370. [Abstract] [PDF]

				D. S. Segal and R. Kuczenski Repeated Binge Exposures to Amphetamine and Methamphetamine: Behavioral and Neurochemical Characterization J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 561 - 573. [Abstract] [Full Text]

				A. Emmi, H. Rajabi, and J. Stewart Behavioral and Neurochemical Recovery from Partial 6-Hydroxydopamine Lesions of the Substantia Nigra Is Blocked by Daily Treatment with D1/D5, But Not D2, Dopamine Receptor Antagonists J. Neurosci., May 15, 1997; 17(10): 3840 - 3846. [Abstract] [Full Text] [PDF]

				D. S. Segal and R. Kuczenski An Escalating Dose "Binge" Model of Amphetamine Psychosis: Behavioral and Neurochemical Characteristics J. Neurosci., April 1, 1997; 17(7): 2551 - 2566. [Abstract] [Full Text] [PDF]

				F. C. Zhou, Y. H. Chiang, and Y. Wang Constructing a New Nigrostriatal Pathway in the Parkinsonian Model with Bridged Neural Transplantation in Substantia Nigra J. Neurosci., November 1, 1996; 16(21): 6965 - 6974. [Abstract] [Full Text] [PDF]

				A. Emmi, H. Rajabi, and J. Stewart Behavioral and Neurochemical Recovery from Partial 6-Hydroxydopamine Lesions of the Substantia Nigra Is Blocked by Daily Treatment with Glutamate Receptor Antagonists MK-801 and CPP J. Neurosci., August 15, 1996; 16(16): 5216 - 5224. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help